| Title: | Metabolic dysfunction-associated fatty liver disease and the risk of gout: a UK Biobank prospective cohort study |
| Journal: | European Journal of Medical Research |
| Published: | 28 Oct 2025 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/41152987/ |
| DOI: | https://doi.org/10.1186/s40001-025-03298-5 |
| URL: | https://eurjmedres.biomedcentral.com/counter/pdf/10.1186/s40001-025-03298-5 |
Publication 16629
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BackgroundGout, an inflammatory arthritis characterized by monosodium urate crystal deposition, affects 1-4% of the global population and demonstrates strong associations with metabolic syndrome. Metabolic dysfunction-associated fatty liver disease (MASLD), affecting 38% of adults worldwide, represents a multisystem disorder with substantial morbidity and mortality. This first European prospective cohort study systematically examines the association between MASLD and incident gout risk.MethodUtilizing UK Biobank data (n = 402,083 after exclusions), we conducted a prospective cohort analysis excluding participants with baseline gout, arthritis, hepatitis B/C, alcohol-related liver disease, or events within the initial 2-year follow-up. Cox proportional hazards models evaluated MASLD-gout associations, with Kaplan-Meier curves illustrating cumulative incidence.ResultMASLD patients exhibited a 71% elevated gout risk versus non-MASLD counterparts (HR = 1.71, 95% CI 1.59-1.83, P < 0.0001). Subgroup analyses revealed consistent associations across demographics, with attenuated risk in older adults (≥ 65 years: HR = 1.55 vs. < 65 years: HR = 1.86). Paradoxically, individuals without diabetes, hypertension, or central obesity demonstrated a higher gout risk than those with these comorbidities. MASLD patients showed significantly greater cumulative gout incidence over time (P < 0.001).ConclusionMASLD independently associates with increased gout risk, persisting after comprehensive confounder adjustment. These findings underscore MASLD's potential role in gout pathogenesis and highlight the clinical relevance of targeted MASLD interventions for gout prevention. Mechanistic and causal investigations remain warranted.</p>
15 Keywords
- Adult
- Aged
- Biological Specimen Banks
- Fatty Liver
- Female
- Gout
- Humans
- Incidence
- Male
- Metabolic Syndrome
- Middle Aged
- Prospective Studies
- Risk Factors
- UK Biobank
- United Kingdom
10 Authors
- Xin Liu
- Yi Wang
- Hui Song
- Zi-bin Tian
- Yan-gang Wang
- Qian Yu
- Chang Li
- Qinghui Niu
- Xiang-jia Zhu
- Ying Chen
1 Application
| Application ID | Title |
|---|---|
| 93118 | Associations of lifestyle risk factors, ocular diseases, and mental disorders. |
Enabling scientific discoveries that improve human health